The Board proposes the development of a rule amendment to address prescribing of controlled substances for treatment of psychiatric disorders via telemedicine.  

  •  

    DEPARTMENT OF HEALTH

    Board of Osteopathic Medicine

    RULE NO.:RULE TITLE:

    64B15-14.0081Standards for Telemedicine Practice

    PURPOSE AND EFFECT: The Board proposes the development of a rule amendment to address prescribing of controlled substances for treatment of psychiatric disorders via telemedicine.

    SUBJECT AREA TO BE ADDRESSED: The prescribing of controlled substances for treatment of psychiatric disorders via telemedicine.

    RULEMAKING AUTHORITY: 459.015(1)(z), FS.

    LAW IMPLEMENTED: 459.015(1)(z), FS.

    IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE REGISTER.

    THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Claudia Kemp, Executive Director, Board of Osteopathic Medicine/MQA, 4052 Bald Cypress Way, Bin #C06, Tallahassee, Florida 32399-3256

    THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS AVAILABLE AT NO CHARGE FROM THE CONTACT PERSON LISTED ABOVE.

Document Information

Subject:
The prescribing of controlled substances for treatment of psychiatric disorders via telemedicine.
Purpose:
The Board proposes the development of a rule amendment to address prescribing of controlled substances for treatment of psychiatric disorders via telemedicine.
Rulemaking Authority:
459.015(1)(z), FS.
Law:
459.015(1)(z), FS.
Contact:
Claudia Kemp, Executive Director, Board of Osteopathic Medicine/MQA, 4052 Bald Cypress Way, Bin #C06, Tallahassee, Florida 32399-3256.
Related Rules: (1)
64B15-14.0081. Standards for Telemedicine Practice